Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 3
2011 4
2012 3
2013 5
2014 4
2015 2
2016 2
2018 3
2019 1
2020 3
2021 2
2022 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Cervicovaginal microbiome and natural history of HPV in a longitudinal study.
Usyk M, Zolnik CP, Castle PE, Porras C, Herrero R, Gradissimo A, Gonzalez P, Safaeian M, Schiffman M, Burk RD; Costa Rica HPV Vaccine Trial (CVT) Group. Usyk M, et al. PLoS Pathog. 2020 Mar 26;16(3):e1008376. doi: 10.1371/journal.ppat.1008376. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32214382 Free PMC article. Clinical Trial.
Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial.
Shing JZ, Hu S, Herrero R, Hildesheim A, Porras C, Sampson JN, Schussler J, Schiller JT, Lowy DR, Sierra MS, Carvajal L, Kreimer AR; Costa Rica HPV Vaccine Trial Group. Shing JZ, et al. Lancet Oncol. 2022 Jul;23(7):940-949. doi: 10.1016/S1470-2045(22)00291-1. Epub 2022 Jun 13. Lancet Oncol. 2022. PMID: 35709811 Free PMC article. Clinical Trial.
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial.
Porras C, Tsang SH, Herrero R, Guillén D, Darragh TM, Stoler MH, Hildesheim A, Wagner S, Boland J, Lowy DR, Schiller JT, Schiffman M, Schussler J, Gail MH, Quint W, Ocampo R, Morales J, Rodríguez AC, Hu S, Sampson JN, Kreimer AR; Costa Rica Vaccine Trial Group. Porras C, et al. Lancet Oncol. 2020 Dec;21(12):1643-1652. doi: 10.1016/S1470-2045(20)30524-6. Lancet Oncol. 2020. PMID: 33271093 Free PMC article. Clinical Trial.
Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial.
Baisley K, Kemp TJ, Kreimer AR, Basu P, Changalucha J, Hildesheim A, Porras C, Whitworth H, Herrero R, Lacey CJ, Schiller JT, Lucas E, Mutani P, Dillner J, Indangasi J, Muwonge R, Hayes RJ, Pinto LA, Watson-Jones D. Baisley K, et al. Lancet Glob Health. 2022 Oct;10(10):e1485-e1493. doi: 10.1016/S2214-109X(22)00306-0. Lancet Glob Health. 2022. PMID: 36113532 Free PMC article. Clinical Trial.
Human papillomavirus testing in the prevention of cervical cancer.
Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE. Schiffman M, et al. J Natl Cancer Inst. 2011 Mar 2;103(5):368-83. doi: 10.1093/jnci/djq562. Epub 2011 Jan 31. J Natl Cancer Inst. 2011. PMID: 21282563 Free PMC article. Review.
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine Trial.
Hu SY, Kreimer AR, Porras C, Guillén D, Alfaro M, Darragh TM, Stoler MH, Villegas LF, Ocampo R, Rodriguez AC, Schiffman M, Tsang SH, Lowy DR, Schiller JT, Schussler J, Quint W, Gail MH, Sampson JN, Hildesheim A, Herrero R; Costa Rica HPV Vaccine Trial (CVT) Group. Hu SY, et al. J Natl Cancer Inst. 2022 Sep 9;114(9):1253-1261. doi: 10.1093/jnci/djac107. J Natl Cancer Inst. 2022. PMID: 35640980 Free PMC article.
Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.
Tsang SH, Basu P, Bender N, Herrero R, Kemp TJ, Kreimer AR, Müller M, Panicker G, Pawlita M, Pinto LA, Sampson JN, Sankaranarayanan R, Schussler J, Sehr P, Sierra MS, Unger ER, Waterboer T, Hildesheim A; Costa Rica Vaccine Trial (CVT) Group. Tsang SH, et al. Vaccine. 2020 Aug 27;38(38):5997-6006. doi: 10.1016/j.vaccine.2020.07.017. Epub 2020 Jul 24. Vaccine. 2020. PMID: 32713678 Free PMC article.
HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial.
Tsang SH, Schiller JT, Porras C, Kemp TJ, Herrero R, Schussler J, Sierra MS, Cortes B, Hildesheim A, Lowy DR, Rodríguez AC, Romero B, Çuburu N, Shing JZ, Pinto LA, Sampson JN, Kreimer AR; Costa Rica HPV Vaccine Trial Group. Tsang SH, et al. NPJ Vaccines. 2022 Mar 29;7(1):40. doi: 10.1038/s41541-022-00431-x. NPJ Vaccines. 2022. PMID: 35351898 Free PMC article.
Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.
Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group. Safaeian M, et al. J Natl Cancer Inst. 2018 Feb 1;110(2):205-12. doi: 10.1093/jnci/djx158. J Natl Cancer Inst. 2018. PMID: 28954299 Free PMC article. Clinical Trial.
37 results